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CMV disease can involve many organs and the gastrointestinal tract is a common site. 2 There are several reports on small intestinal endoscopic findings of GVHD detected by capsule endoscopy, [3] [4] [5] [6] but only limited information has been published regarding endoscopic findings of CMV enteritis after Allo-HSCT using capsule endoscopy. 4 We report herein a case of CMV enteritis involving the small intestine after Allo-HSCT that was detected by capsule endoscopy.
A 58-year-old man with myelodysplastic syndrome underwent Allo-HSCT with HLA mismatched unrelated cord blood at the National Cancer Center Hospital in Tokyo, Japan. The conditioning regimen consisted of fludarabine (125 mg/m 2 ), melphalan (80 mg/m 2 ) and 4 Gy TBI. Tacrolimus was administered for GVHD prophylaxis.
The transplantation course was uneventful for 7 months, but the patient then started experiencing epigastric pain and watery diarrhea. Total colonoscopy revealed several erosions surrounding a single ulceration in the ascending colon ( Figure 1a ). Biopsy specimens obtained from the ulceration and erosions showed enlarged endothelial cells with nuclear inclusion bodies (Figure 2a ) that were positive for CMV by immunohistochemical staining (Figure 2b) . No definite histological feature to support GVHD was found. A simultaneous CMV antigenemia assay using the monoclonal antibody C7-HRP (Teijin, Tokyo, Japan) indicated two positive cells per 44 000 cells. A subsequent capsule endoscopy (PillCam SB, Given Imaging Inc., Israel) also revealed a single ulceration with satellite erosions in the jejunum, but we were unable to perform a biopsy because of the primary limitation of capsule endoscopy, that is, lack of any biopsy capability. The ulceration in the jejunum was very similar to the one found in the ascending colon (Figure 1b) .
Antiviral therapy was started with ganciclovir (10 mg/kg/ day) followed by foscarnet (60 mg/kg/day) for 6 weeks and the patient's symptoms resolved completely. A follow-up CMV antigenemia assay was negative and endoscopic findings by capsule endoscopy and total colonoscopy revealed healing scars without any active lesions.
Intestinal complications after Allo-HSCT predominantly affect the small intestine, 7 but macroscopic findings of small intestinal disorders following Allo-HSCT have not been fully investigated. Traditional small bowel examinations such as push enteroscopy are somewhat invasive in nature and most patients undergoing Allo-HSCT cannot tolerate such procedures due to the seriousness of their condition. Capsule endoscopy is now widely accepted for small intestinal investigation as being far less invasive. In the present case, this advanced technology enabled us to obtain clear endoscopic images of CMV enteritis in the small intestine after Allo-HSCT.
CMV antigenemia assay is one of the most widely used methods to detect CMV reactivation in a variety of clinical settings; 8 however, it is of little value in predicting and diagnosing gastrointestinal CMV disease. 9 The differential diagnosis of intestinal disorders following Allo-HSCT includes intestinal GVHD, thrombotic microangiopathy, treatment-related toxicities and clostridium difficile enterocolitis as well as CMV enterocolitis. 7 Actual diagnosis is usually based on pathological examinations of endoscopically obtained mucosal biopsy specimens, but this is not possible with capsule endoscopy due to its lack of biopsy capability.
In the present case, we were able to make a diagnosis of CMV enteritis in the small bowel without histological biopsy because of similar coincident findings in the ascending colon that were proven by pathological examination to be CMV colitis. This diagnosis was subsequently confirmed clinically by prompt resolution of intestinal symptoms, endoscopic findings and CMV antigenemia assay after antiviral treatment using ganciclovir and foscarnet.
Fortunately, CMV enteritis involved both the small intestine and colon in this case. CMV colitis, which was proven by biopsy, was a factor in diagnosing small intestinal CMV disease; however, CMV enteritis involving only the small intestine without colon involvement may not be rare after Allo-HSCT because the small intestine is a frequent and severe site for gastrointestinal complications following Allo-HSCT. 7 In such a situation, our picture ( Figure 1a Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan E-mail: yakakuga@ncc.go.jp 
